buyout·deskPrivate equity, daily
Thu, Aug 6, 2026
Daily briefThursday, August 6, 2026
13 deals tracked · Updated 12:07 PM PDT·Full deal sheet
Secondary·Healthcare/Healthcare Technology·August 6, 2026

WindRose Health Investors backs Verified Clinical Trials

The company's secure global database is utilized by pharmaceutical sponsors, CROs, and research sites to improve participant safety and data integrity.

Takeaways

  • Verified Clinical Trials is a provider of clinical trial subject registry and patient safety solutions.
  • WindRose Health Investors is investing in Verified Clinical Trials.
  • The business serves clinical trials, pharmaceutical sponsors, CROs.
BuyerWindRose Health Investors
TargetVerified Clinical Trials
SponsorWindRose Health Investors
TypeSecondary
IndustryHealthcare
Sub-sectorHealthcare Technology

WindRose Health Investors recapitalized Verified Clinical Trials, a provider of clinical trial subject registry solutions that detect and help prevent duplicate enrollment and protocol violations.

The company's secure global database is utilized by pharmaceutical sponsors, CROs, and research sites to improve participant safety and data integrity.

As part of the transaction, WindRose appointed Howard Miller as Chief Executive Officer, with founders Dr. Mitchell Efros and Kerri Weingard remaining actively involved.